1.78
price down icon1.11%   -0.02
after-market Handel nachbörslich: 1.78
loading
Schlusskurs vom Vortag:
$1.80
Offen:
$1.82
24-Stunden-Volumen:
10,525
Relative Volume:
0.79
Marktkapitalisierung:
$12.59M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-33.65M
KGV:
-0.40
EPS:
-4.45
Netto-Cashflow:
$-20.83M
1W Leistung:
+0.56%
1M Leistung:
+19.46%
6M Leistung:
-21.24%
1J Leistung:
-41.64%
1-Tages-Spanne:
Value
$1.75
$1.82
1-Wochen-Bereich:
Value
$1.75
$1.8812
52-Wochen-Spanne:
Value
$1.15
$3.499

Minerva Neurosciences Inc Stock (NERV) Company Profile

Name
Firmenname
Minerva Neurosciences Inc
Name
Telefon
617-600-7373
Name
Adresse
1601 TRAPELO ROAD, WALTHAM, MA
Name
Mitarbeiter
8
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-05
Name
Neueste SEC-Einreichungen
Name
NERV's Discussions on Twitter

Vergleichen Sie NERV mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
NERV
Minerva Neurosciences Inc
1.78 12.59M 0 -33.65M -20.83M -4.45
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Minerva Neurosciences Inc Stock (NERV) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2020-06-08 Bestätigt H.C. Wainwright Buy
2020-05-14 Eingeleitet BTIG Research Buy
2019-10-02 Bestätigt Chardan Capital Markets Buy
2019-09-25 Eingeleitet Chardan Capital Markets Buy
2019-09-18 Eingeleitet William Blair Outperform
2019-05-31 Eingeleitet H.C. Wainwright Buy
2017-09-01 Eingeleitet Citigroup Buy
2017-03-06 Fortgesetzt Jefferies Buy
2016-05-12 Fortgesetzt Jefferies Buy
Alle ansehen

Minerva Neurosciences Inc Aktie (NERV) Neueste Nachrichten

pulisher
Jun 12, 2025

Citadel Advisors LLC Makes New Investment in Kuke Music Holding Limited (NYSE:KUKE) - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Citadel Advisors LLC Purchases New Holdings in Jiuzi Holdings, Inc. (NASDAQ:JZXN) - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Minerva Neurosciences, Inc. (NASDAQ:NERV) Shares Bought by Citadel Advisors LLC - Defense World

Jun 12, 2025
pulisher
Jun 10, 2025

Minerva Neurosciences Reports Q1 2025 Earnings and Regulatory Challenges - TipRanks

Jun 10, 2025
pulisher
Jun 04, 2025

Major Depressive Disorder Pipeline Appears Robust With 75+ Key Companies Actively Working in the Therapeutics Segment | DelveInsight - The Globe and Mail

Jun 04, 2025
pulisher
Jun 04, 2025

Minerva Neurosciences, Inc. (NASDAQ:NERV) Shares Bought by Northern Trust Corp - Defense World

Jun 04, 2025
pulisher
May 23, 2025

Minerva Neurosciences (NASDAQ:NERV) Coverage Initiated at Wall Street Zen - Defense World

May 23, 2025
pulisher
May 14, 2025

Minerva Neurosciences: Q1 Earnings Snapshot - CT Insider

May 14, 2025
pulisher
May 13, 2025

Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates - GlobeNewswire

May 13, 2025
pulisher
May 13, 2025

NERV's Cash Reserves Decrease by $4.1 Million in Q1 2025 | NERV Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Minerva Neurosciences Reports First Quarter 2025 Financial Resul - GuruFocus

May 13, 2025
pulisher
May 13, 2025

MINERVA NEUROSCIENCES Earnings Results: $NERV Reports Quarterly Earnings - Nasdaq

May 13, 2025
pulisher
May 13, 2025

Minerva Neurosciences, Inc. SEC 10-Q Report - TradingView

May 13, 2025
pulisher
May 13, 2025

Minerva Neurosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Minerva Neurosciences (NASDAQ:NERV) Coverage Initiated by Analysts at StockNews.com - Defense World

May 13, 2025
pulisher
May 06, 2025

Minerva Neurosciences (NERV) Expected to Announce Quarterly Earnings on Wednesday - Defense World

May 06, 2025
pulisher
May 06, 2025

Renaissance Technologies LLC Has $285,000 Stock Holdings in Minerva Neurosciences, Inc. (NASDAQ:NERV) - Defense World

May 06, 2025
pulisher
May 05, 2025

Minerva Neurosciences (NASDAQ:NERV) Now Covered by Analysts at StockNews.com - Defense World

May 05, 2025
pulisher
May 01, 2025

Schizophrenia Market to Witness Significant Growth by 2034 Across 7MM as New Therapies Enter Late-Stage Trials | DelveInsight - GlobeNewswire Inc.

May 01, 2025
pulisher
May 01, 2025

Schizophrenia Market to Witness Significant Growth by 2034 - GlobeNewswire

May 01, 2025
pulisher
Apr 27, 2025

StockNews.com Initiates Coverage on Minerva Neurosciences (NASDAQ:NERV) - Defense World

Apr 27, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 19, 2025

Minerva Neurosciences (NASDAQ:NERV) Share Price Crosses Below 200 Day Moving Average – What’s Next? - Defense World

Apr 19, 2025
pulisher
Apr 19, 2025

Minerva Neurosciences (NASDAQ:NERV) Earns Sell Rating from Analysts at StockNews.com - Defense World

Apr 19, 2025
pulisher
Apr 14, 2025

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Apr 14, 2025
pulisher
Apr 13, 2025

StockNews.com Begins Coverage on Minerva Neurosciences (NASDAQ:NERV) - The AM Reporter

Apr 13, 2025
pulisher
Apr 10, 2025

CLASS ACTION UPDATE for TILE, NERV and QSR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders - ACCESS Newswire

Apr 10, 2025
pulisher
Apr 09, 2025

CLASS ACTION UPDATE for BABA, NAK and NERV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders - ACCESS Newswire

Apr 09, 2025
pulisher
Apr 08, 2025

Parkinson's Disease Pipeline Analysis and Clinical Trials - openPR.com

Apr 08, 2025
pulisher
Apr 04, 2025

Minerva Neurosciences stock hits 52-week low at $1.29 - Investing.com Australia

Apr 04, 2025
pulisher
Apr 04, 2025

Minerva Neurosciences stock hits 52-week low at $1.29 By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Mar 24, 2025

Major depressive disorder Drugs Market 2034: Clinical Trials, - openPR.com

Mar 24, 2025
pulisher
Mar 20, 2025

Minerva Neurosciences regains Nasdaq compliance By Investing.com - Investing.com Australia

Mar 20, 2025
pulisher
Mar 20, 2025

Minerva Neurosciences regains Nasdaq compliance - Investing.com India

Mar 20, 2025
pulisher
Mar 19, 2025

FINAL DEADLINE ALERT: ROSEN, LEADING AND RESPECTED INVESTOR COUNSEL, Encourages Minerva Neurosciences, Inc. Investors with Large Losses to Secure Counsel Before Important February 8 Deadline – NERV - Business Wire

Mar 19, 2025
pulisher
Mar 13, 2025

Parkinson's Disease Clinical Pipeline | 130+ Companies Advancing the Future of Treatment - openPR

Mar 13, 2025
pulisher
Mar 07, 2025

Intra-Cellular deal, Axsome settlement drive neurological index recovery - BioWorld MedTech

Mar 07, 2025
pulisher
Mar 05, 2025

Minerva Neurosciences Reports Improved 2024 Financials - TipRanks

Mar 05, 2025
pulisher
Mar 02, 2025

Minerva Neurosciences (NASDAQ:NERV) Coverage Initiated at StockNews.com - Defense World

Mar 02, 2025

Finanzdaten der Minerva Neurosciences Inc-Aktie (NERV)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
Kapitalisierung:     |  Volumen (24h):